CAPSTONE INVESTMENT ADVISORS, LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AD2. A total of 47 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$15,164,175
+3.5%
15,450,0000.0%0.07%
-5.6%
Q2 2023$14,648,531
-10.6%
15,450,000
-13.9%
0.07%
-13.3%
Q1 2023$16,379,375
-1.7%
17,950,0000.0%0.08%
-31.4%
Q4 2022$16,659,844
-10.3%
17,950,000
-4.0%
0.12%
+8.0%
Q3 2022$18,571,000
+25.4%
18,700,000
+15.4%
0.11%
+55.6%
Q2 2022$14,812,00016,200,0000.07%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 127,800,000$118,341,5222.45%
Boussard & Gavaudan Investment Management LLP 17,500$16,097,1751.78%
BRAIDWELL LP 52,740,000$48,949,3131.64%
WOLVERINE ASSET MANAGEMENT LLC 109,030,000$101,603,4461.05%
Sonora Investment Management Group, LLC 9,195,000$8,531,7560.78%
CSS LLC/IL 11,966,000$11,133,2860.63%
MACKAY SHIELDS LLC 24,332,000$22,563,5420.58%
SSI INVESTMENT MANAGEMENT LLC 6,935,000$6,401,8740.41%
ADVENT CAPITAL MANAGEMENT /DE/ 18,450,000$17,123,9060.30%
Magnetar Financial LLC 16,700,000$15,5100.26%
View complete list of IONIS PHARMACEUTICALS INC shareholders